Paysign, Inc. (NASDAQ:PAYS – Get Free Report) insider Matthew Louis Lanford sold 25,360 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $3.96, for a total value of $100,425.60. Following the sale, the insider now directly owns 109,731 shares of the company’s stock, valued at $434,534.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Paysign Price Performance
Shares of Paysign stock traded down $0.17 on Wednesday, hitting $3.68. The company had a trading volume of 134,817 shares, compared to its average volume of 251,627. The company has a market cap of $197.06 million, a PE ratio of 25.60 and a beta of 0.95. Paysign, Inc. has a 52 week low of $2.22 and a 52 week high of $5.59. The business has a 50-day simple moving average of $3.96 and a 200-day simple moving average of $4.34.
Paysign (NASDAQ:PAYS – Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.01 by $0.02. Paysign had a net margin of 14.28% and a return on equity of 30.64%. The firm had revenue of $15.26 million for the quarter, compared to analyst estimates of $14.96 million. During the same period in the previous year, the business earned $0.02 EPS. On average, equities research analysts predict that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Paysign
Analysts Set New Price Targets
Separately, Barrington Research reissued an “outperform” rating and issued a $7.00 target price on shares of Paysign in a report on Monday, November 4th.
Read Our Latest Stock Report on PAYS
About Paysign
Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.
Further Reading
- Five stocks we like better than Paysign
- How Investors Can Find the Best Cheap Dividend Stocks
- Rocket Lab is the Right Stock for the Right Time
- Profitably Trade Stocks at 52-Week Highs
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- The Basics of Support and Resistance
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.